Clinical trial
Long-term Follow-up of Interleukin-1B and H+,K+-ATPase mRNA Expression After Helicobacter Pylori Eradication
NCT04037904 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Follow-up of Interleukin-1B and H+,K+-ATPase mRNA Expression After Helicobacter Pylori Eradication
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- December 31, 2022
- Enrollment
- 490 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori infection